Professional
Added to YB: 2025-03-07
Pitch date: 2025-01-30
LFCR [neutral]
Lifecore Biomedical, Inc.
+28.34%
current return
Author Info
Greenhaven Road is a boutique hedge fund with the patience and confidence to step outside of the norm. Visit their website.
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States.
Market Cap
$298.2M
Pitch Price
$6.07
Price Target
20.00 (+157%)
Dividend
N/A
EV/EBITDA
-128.16
P/E
-6.25
EV/Sales
3.62
Sector
Life Sciences Tools and Services
Category
growth
Greenhaven Road Capital Main Fund Portfolio Holding: Lifecore Biomedical, Inc.
LFCR (update): CDMO can triple production w/o capex. Alcon destocking done, contractual volume step-ups ($25M-$50M+) by 2027. New CEO hints at tech transfers & large contract potential. EBITDA margins to rise 15% to 25%+. $300M rev, 25% EBITDA, 15x multiple = $20/share vs. $7 now. CEO bought shares, contract tied to stock price.
Read full article (2 min)